Baroda BNP Paribas Health and Wellness Fund Regular IDCW
NAV ₹11.0539 on 13 November 2026
AMFI name: Baroda BNP Paribas Health and Wellness Fund Regular IDCWPayout · Scheme code 153607
IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | NIFTY 500 TRI | Category median |
|---|---|---|---|
| 1M | +8.69% | +7.53% | +5.63% |
| 6M | +11.04% | +6.80% | +6.99% |
| 1Y | +14.75% | +0.54% | +2.83% |
| 3Y | - | +12.13% | +13.18% |
| 5Y | - | +9.87% | +10.85% |
Benchmark: NIFTY 500 TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare Total Return Index, which we do not hold, so this is the closest NSE index.
Category median: the middle return among Regular plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.
Rank among peers
Regular plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Nippon India Mutual Fund | +46.52% | +60.64% | 1.07 | 1.06% | ₹1,100 Cr |
| #2 | HDFC Mutual Fund | +33.64% | +20.34% | 1.07 | 0.89% | ₹11,128 Cr |
| #3 | HDFC Mutual Fund | +31.28% | +31.60% | 1.76 | 1.03% | ₹3,128 Cr |
| #4 | SBI Mutual Fund | +25.42% | +26.07% | 1.47 | 0.76% | ₹5,565 Cr |
| #5 | HDFC Mutual Fund | +24.77% | +10.10% | 1.09 | 1.10% | ₹1,997 Cr |
| #6 | Mirae Asset Mutual Fund | +24.42% | +27.89% | 1.28 | - | ₹3,458 Cr |
| #7 | UTI Mutual Fund | +23.89% | +22.00% | 1.31 | 1.35% | ₹1,399 Cr |
| #8 | ICICI Prudential Mutual Fund | +22.73% | +10.29% | 0.95 | 2.08% | ₹3,926 Cr |
| #- | Baroda BNP Paribas Health and Wellness FundCurrent Fund Baroda BNP Paribas Mutual Fund | - | +14.75% | - | 1.47% | ₹511 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 1.47% · Regular 2.70%
- Exit load
- Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment- Exit load -NIL For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment- 1.00% of applicable NAV For redemption/switch out of units after 1 year from the date of allotment-Nil
- Fund size (all plans)
- ₹511 CrAverage, quarter to September 2026
- Benchmark
- BSE Healthcare Total Return IndexCompared here with NIFTY 500 TRI
- Allotment date
- 27 June 2025Scheme document
- Type
- An open ended equity scheme investing in Pharma and Healthcare sector
- AMFI scheme code
- 153607
Fund managers (2)
- Rohan Korde
- Ankeet Pandya
How each manager has done since taking over: fund manager scorecard.
Investment objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.
About this fund
Baroda BNP Paribas Health and Wellness Fund Regular IDCW is a mutual fund scheme from Baroda BNP Paribas Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Regular plan with the IDCW option. Its NAV was ₹11.0539 on 13 November 2026. Its NAV changed by 14.75% over 1 year. These figures leave out IDCW payouts, so they understate what investors received. Its benchmark, NIFTY 500 TRI, returned 0.54% over 1 year. The fund house rates its risk as “Very high” on the SEBI riskometer. Its average assets under management were ₹511 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 2.70% a year for the Regular plan. Managed by Rohan Korde and Ankeet Pandya. Its scheme summary document gives the allotment date as 27 June 2025.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.